Erythropoiesis-stimulating agents in sickle cell anaemia

被引：14
|
作者：
Han, Jin [1 ,2 ,3 ]
Zhou, Jifang [3 ]
Kondragunta, Vinod [1 ]
Zhang, Xu [1 ]
Molokie, Robert E. [1 ]
Gowhari, Michel [1 ]
Hassan, Johara [1 ]
Jain, Shivi [1 ]
Calip, Gregory S. [3 ]
Gordeuk, Victor R. [1 ]
Saraf, Santosh L. [1 ]
机构：
[1] Univ Illinois, Dept Med, Ctr Comprehens Sickle Cell, Div Hematol & Oncol, Chicago, IL 60607 USA
[2] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA
[3] Univ Illinois, Ctr Pharmacoepidemiol & Pharmacoecon Res, Chicago, IL USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 182卷 / 04期
基金：
美国国家卫生研究院;
关键词：
sickle cell anaemia; erythropoietin; darbepoetin; erythropoiesis-stimulating agents; RECOMBINANT-HUMAN-ERYTHROPOIETIN; RENAL-FAILURE; HYDROXYUREA;
D O I：
10.1111/bjh.14846
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：602 / 605
页数：4
相关论文
共 50 条
  • [1] Erythropoiesis-Stimulating Agents in Renal Medicine
    Locatelli, Francesco
    Del Vecchio, Lucia
    ONCOLOGIST, 2011, 16 : 19 - 24
  • [2] Internal medicine, renal anaemia, and erythropoiesis-stimulating agents (ESAS)
    Veys, N.
    Van Biesen, W.
    Lameire, N.
    ACTA CLINICA BELGICA, 2007, 62 (06) : 396 - 407
  • [3] Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients
    Ngo, Katherine
    Kotecha, Dipak
    Walters, Julia A. E.
    Manzano, Luis
    Palazzuoli, Alberto
    van Veldhuisen, Dirk J.
    Flather, Marcus
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):
  • [4] Tumor Progression Associated with Erythropoiesis-Stimulating Agents
    Newland, Ashley M.
    Black, Curtis D.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (12) : 1865 - 1870
  • [5] Erythropoiesis-stimulating agents: development, detection and dangers
    Franz, Stefan E.
    DRUG TESTING AND ANALYSIS, 2009, 1 (5-6) : 245 - 249
  • [6] Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation
    Martino, Massimo
    Lanza, Francesco
    Demirer, Taner
    Moscato, Tiziana
    Secondino, Simona
    Pedrazzoli, Paolo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (02) : 195 - 211
  • [7] The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib
    Crisa, Elena
    Cilloni, Daniela
    Elli, Elena M.
    Martinelli, Vincenzo
    Palumbo, Giuseppe A.
    Pugliese, Novella
    Beggiato, Eloise
    Frairia, Chiara
    Cerrano, Marco
    Lanzarone, Giuseppe
    Marchetti, Monia
    Mezzabotta, Mauro
    Boccadoro, Mario
    Ferrero, Dario
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (05) : 701 - 704
  • [8] Erythropoiesis-stimulating agents: Past and future
    Nangaku, M.
    Fliser, D.
    KIDNEY INTERNATIONAL, 2007, 72 : S1 - S3
  • [9] Thrombotic Complications of Erythropoiesis-Stimulating Agents
    Lippi, Giuseppe
    Franchini, Massimo
    Favaloro, Emmanuel J.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2010, 36 (05) : 537 - 549
  • [10] Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients
    Hahn, Deirdre
    Esezobor, Christopher I.
    Elserafy, Noha
    Webster, Angela C.
    Hodson, Elisabeth M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (01):
12345